However, ZNF671 was negatively associated with DNA damage in ODG (R = −0.11; **P < 0.01); with hypoxia (R = −0.55; *P < 0.05), EMT (R = −0.50; *P < 0.05), apoptosis (R = −0.49; *P < 0.05), angiogenesis (R = −0.48; *P < 0.05), and quiescence (R = −0.43; *P < 0.05) in glioma (PDX), and with inflammation (R = −0.20; *P < 0.05) and differentiation (R = −0.18; *P < 0.05) in BRCA (Figures 3, 4). This evidence concerns the gene ZNF671 and central nervous system cancer.